Friday, December 8, 2023
Business

Genuine Parts Q2 2023 Earnings Preview

By Josh Turnrow
0
49
genuine-parts-q2-2023-earnings-preview

Must read

Business

Gilead Sciences on track to snap its six-day winning streak

Xina Derwin - 0
Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....
Read more
Business

AbbVie shares set for seventh straight session of gains

Xina Derwin - 0
AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...
Read more
Business

Meta Platforms on track to snap six-day red streak

Xina Derwin - 0
Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....
Read more
Business

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Xina Derwin - 0
Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...
Read more
Josh Turnrow

Jul. 19, 2023 12:40 PM ETGenuine Parts Company (GPC)By: Deepa Sarvaiya, SA News Editor

  • Genuine Parts (NYSE:GPC) is scheduled to announce Q2 earnings results on Thursday, July 20th, before market open.
  • The consensus EPS Estimate is $2.34 (+6.4% Y/Y) and the consensus Revenue Estimate is $5.96B (+6.4% Y/Y).
  • Over the last 2 years, GPC has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
  • Over the last 3 months, EPS estimates have seen 1 upward revision and 9 downward. Revenue estimates have seen 3 upward revisions and 6 downward.

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Previous article3 stocks to watch from the Communication Services sector as earnings approach
Next articleSnap-On Q2 2023 Earnings Preview

More articles

Business

Gilead Sciences on track to snap its six-day winning streak

Xina Derwin - 0
Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....
Read more
Business

AbbVie shares set for seventh straight session of gains

Xina Derwin - 0
AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...
Read more
Business

Meta Platforms on track to snap six-day red streak

Xina Derwin - 0
Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....
Read more

Latest article

Business

Gilead Sciences on track to snap its six-day winning streak

Xina Derwin - 0
Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....
Read more
Business

AbbVie shares set for seventh straight session of gains

Xina Derwin - 0
AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...
Read more
Business

Meta Platforms on track to snap six-day red streak

Xina Derwin - 0
Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....
Read more
Business

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Xina Derwin - 0
Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...
Read more
Business

FedEx shares on track to record its seventh straight session of gains

Xina Derwin - 0
Sundry Photography/iStock Editorial via Getty Images Global delivery firm FedEx (NYSE:FDX) shares are on track to record its seventh...
Read more
LA Journal Mag is your culture, Business, Politics, and much more news. We provide you with the latest news straight from the industry.

POPULAR POSTS

POPULAR CATEGORY

© 2023 - LA Journal Mag